New techniques for selective immune suppression increase transplant odds.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003524:Cyclosporins; D004322:Drainage; D006085:Graft Survival / Q000187:drug effects; D000882:Haplorhini; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017053:Infection Control; D016030:Kidney Transplantation; D016040:Lung Transplantation; D008208:Lymphatic System / Q000528:radiation effects; D008212:Lymphocyte Depletion; D051379:Mice; D010456:Peptides, Cyclic / Q000627:therapeutic use; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013897:Thoracic Duct / Q000601:surgery; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D010456:Peptides, Cyclic